New Federal State Of China | Whistleblower Movement

Weekly Review Of The Pandemic And Vaccination Information

From May 11 to 18, 2022, excluding Communist China, over 3.87 million new cases of the CCP virus were reported worldwide, essentially flat with the 3.82 million new cases last week. In addition, there were 11,416 new deaths confirmed this week, a sharp decline of 14.9% from 13,411 deaths last week.As of May 18, excluding Communist China, the world has received a total of 8.52 billion doses of the CCP virus vaccine, an increase of 0.59% from the data reported on May 11. The global vaccination against the CCP virus has remained stable, with the average growth rate below 1% for 11 consecutive weeks.On May 13th, Halifax-class frigate Winnipeg of Royal Canadian Navy was hit by an outbreak of the CCP virus, with seven officers and soldiers testing positive, while training in preparation for an overseas deployment at sea.On May 17th, the U.S. Food and Drug Administration approved Pfizer’s CCP virus vaccine booster for children aged 5 to 11. Given that 28.8% of children within this age group are fully vaccinated, it is unclear how many parents will have their children receive a third shot.

On May 18th, the European Medicines Agency (EMA) accepted the marketing authorization application filed by Valneva, a special vaccine company, for its inactivated CCP virus vaccine, VLA2001.
Subsequently, if the EMA’s Committee for Human Medicinal Products (CHMP) gives a positive opinion about VLA2001, the European Commission will review the recommendation and make a final decision.

On the same day, the White House CCP virus coordinator, Dr. Ashish Jha, warned that the U.S. could not buy updated CCP virus vaccines for all Americans later this year without more funding from Congress.

Picture of Aussie Brief News

Aussie Brief News

Go to First Page and Get the Latest News.

Translator : MOS Buddhism Team – Ronald Yan
Design&editor: Hbamboo

Leave a Reply

Your email address will not be published. Required fields are marked *